×

Roche Pharma CEO on Alexion deal rumors

2:25 AM ET Thu, 25 July 2013

Daniel O'Day, CEO of Roche's pharma unit, declines to comment on Alexion deal talks, but says the company is keen on incorporating innovations into its portfolio.